Management Team
The management team of Cognos Therapeutics Inc. (Cognos) is committed to excellence in leadership and strategic innovation in its pursuit of the vision and goals established by the Cognos Board of Directors. The executive team is comprised of seasoned and forward thinking individuals who have each achieved success in their areas of expertise with previous companies. Not only is their leadership well recognized, but more importantly is their ability to inspire and direct the teams and individuals who are working to bring Cognos’ unique product technology to commercial viability.

Frank Adell
Chief Executive Officer

Josh Shachar
Chief Innovation Officer

Thomas Chen, MD, PhD
Chief Neuro-Surgeon and Oncology Officer

Winston Wu, PhD
Senior Vice President of Product Development and Chief Technology Officer

Dr. SUSAN ALPERT, MD, PhD
Lead Regulatory Consultant
Dr. Alpert brings over three decades of experience in helping organizations like the FDA, Medtronic and Accelmed in setting and achieving the standards of compliance for regulatory acceptance of advanced medical technologies.

Thomas Lobl, PhD
Chief Operating Officer

Darci Diage
Manager, Special Medical Device Regulatory and Compliance

Dr. Ian Welsford, PhD
Chief Regulatory and Compliance Office